Safety Study of Weekly Semaglutide in Chilean Participants With Type 2 Diabetes

NCT05533632 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

104

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Semaglutide

Sponsor

Novo Nordisk A/S